- gsearch

Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov

Advanced Search

- gsearch

Search Results

Narrow Results:

2019 1

Journal Article 1

1 Results

Refine Results

All Collections

Refine Results:

All Collections

Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects

CITE Title : Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects Personal Author(s) : Mofenson, Lynne M;Pozniak, Anton L;Wambui, Jacque;Raizes, Elliot;Ciaranello, Andrea;Clayden, Polly;Ehrenkranz, Peter;Fakoya, Ade;Hill, Andrew;Khoo, Saye;Mahaka, Imelda;Modi, Surbhi;Moore, Cynthia;Phillips, Andrew;Siberry, George;Sikwese, Kenly;Thorne, Claire;Watts, Heather D;Doherty, Meg;Ford, Nathan P; Published Date : Jul 2019 Source : J Int AIDS Soc. 22(7) URL : https://stacks.cdc.gov/view/cdc/81491 Mofenson, Lynne M et al. (2019). Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects. 22(7). Mofenson, Lynne M et al. "Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects" 22, no. 7 (2019) Mofenson, Lynne M et al. "Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects" vol. 22, no. 7, 2019 Export RIS Citation Information.

:

Mofenson, Lynne M ;

Pozniak, Anton L

Jul 2019 | J Int AIDS Soc. 22(7)

:

IntroductionThe unexpected identification of a neural tube defect (NTD) safety signal with preconception dolutegravir (DTG) exposure in the Botswana T...

To see more results, try removing search filters or changing the search terms